Morgan Stanley Invo Bioscience, Inc. Transaction History

Morgan Stanley

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Oct 27, 2022	SELL	$0.64 - $2.66 $3 - $13	-5 Reduced 0.59%	843 $1,000
Q2 2022 Aug 15, 2022	SELL	$0.64 - $2.66 $3 - $13	-5 Reduced 0.59%	843 $1,000
Q1 2022 Oct 27, 2022	BUY	$2.19 - $3.82 $10 - $19	5 Added 0.59%	848 $2,000
Q1 2022 May 13, 2022	BUY	$2.19 - $3.82 $10 - $19	5 Added 0.59%	848 $2,000
Q3 2021 Nov 15, 2021	BUY	$3.17 - $4.61 $2,672 - $3,886	843 New	843 $3,000

14.1K

Ticker INVO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,169,700
Market Cap $10.1M
Description
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.